Dr. Shakti Nagpal is an early-career researcher specializing in drug delivery, nanomedicine, biopharmaceutics, and PBPK modeling. He earned his Ph.D. from the National University of Singapore (NUS), where his research focused on physiologically based biopharmaceutics modeling of nano-carriers and high-throughput development of liposomal formulations. His work has been published in high-impact journals, including ACS Nano and the Journal of Controlled Release. His research interests include nanoformulations, nanomedicine biopharmaceutics, physiologically based pharmacokinetic (PBPK) modeling for nanoformulations, design-converged formulation strategies, disposition risk assessment, biorelevant in vitro release testing and performance testing of lipid-based systems, particularly liposomes. Dr. Nagpal has received several honors, including the ISPE APAC Best Poster Presentation Award, ISPE Foundation Travel Grant, ISPE Emerging Leaders Hackathon Award, NUS Faculty of Science Conference Award and the NUS Graduate Teaching Assistant Award. He began his career at Dr. Reddy’s Laboratories and contributed to preclinical formulation development at the Institute of Nano Science and Technology (INST). He is currently an IRTA Postdoctoral Fellow at NCATS, NIH, advancing translational research in drug discovery and delivery.